Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
A, Diagram of the proglucagon gene and encoded mRNA
Retatrutide is an investigational triple receptor agonist that simultaneously targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Through its dual insulinotropic and glucagonotropic effects on stabilizing glucose levels, GIP could provide a buffer against hyperglycemia when large amounts of glucose are consumed and mitigate reactive hypoglycemia, especially after meals with high fat content
If you are working with compounded semaglutide in lyophilized form, you also need bacteriostatic water for reconstitution
Functional MRI studies have demonstrated that GLP-1 agonists reduce brain activation in response to alcohol cues in reward-relevant regions
It also enhances insulin sensitivity and regulates blood sugar levels, leading to improved metabolic health and weight control
US$ 24.60
US$ 26.75
US$ 25.04
US$ 29.29
US$ 20.16
US$ 25.85
